Efficacy of transcatheter low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism. Study rationale and design
Authors:
- M. A. SimakovaMSM. A. Simakova
- S. I. ParkhomenkoSPS. I. Parkhomenko
- K. B. LapshinKLK. B. Lapshin
- T. D. GlebovskayTGT. D. Glebovskay
- D. V. KarpovaDKD. V. Karpova
- K. N. MalikovKMK. N. Malikov
- Ekaterina Leonidovna UrumovaEUEkaterina Leonidovna Urumova
- A. V. BerezinaABA. V. Berezina
- D. D. ZubarevDZD. D. Zubarev
- N. V. MarukyanNMN. V. Marukyan
- O. M. MoiseevaOMO. M. Moiseeva
Open Access
- 29 April 2025
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (3) , 6060
Abstract
Aim. Comparison of conservative and invasive treatment strategies in patients with intermediate-high risk pulmonary embolism (PE) based on a multimodal assessment of efficacy and safety.Material and methods. This single-center, open-label, randomized, comparative trial will include 100 patients with a verified diagnosis of PE with intermediate-high risk of 30-day mortality. Patients will be randomized 1:1 to standard anticoagulant therapy or selective low-dose alteplase transcatheter thrombolysis. Patients will be followed for 12 months. The primary endpoint is a decrease in the right ventricle to left ventricle ratio by 20% or more from baseline at 48±6 hours after initiation of therapy. There are secondary endpoints: patient hemodynamic instability; ISTH major bleeding; Qanadli index decrease at 48 hours; degree of residual thrombosis with reduced perfusion at 3-6 months; incidence of post-thromboembolic syndrome at 3-6 months; 30-day, 90-day, and 1-year mortality.Conclusion. The study will provide important clinical data on the short- and long-term efficacy and safety of different treatment approaches in patients with intermediate-to-high-risk acute pulmonary embolism.Keywords
This publication has 34 references indexed in Scilit:
- Prevalence of long-term right ventricular dysfunction after acute pulmonary embolism: a systematic review and meta-analysiseClinicalMedicine, 2023
- Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO studyAmerican Heart Journal, 2022
- Indigo Aspiration System for Treatment of Pulmonary EmbolismJACC: Cardiovascular Interventions, 2021
- A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary EmbolismJACC: Cardiovascular Interventions, 2018
- A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertensionLa radiologia medica, 2017
- Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismJACC, 2017
- A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary EmbolismJACC: Cardiovascular Interventions, 2015
- Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial HemorrhageJAMA, 2014
- Interventricular Mechanical Asynchrony in Pulmonary Arterial HypertensionJACC, 2008
- The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary diseaseThe American Journal of Cardiology, 1971